Literature DB >> 803853

Urinary fibrin-fibrinogen degradation products in nephrotic syndrome.

C L Hall, N Pejhan, J M Terry, J D Blainey.   

Abstract

The urinary concentration of fibrin-fibrinogen degradation products (F.D.P.) was measured in 90 patients with proteinuria above 2 g/1 and correlated with proteinuria, differential protein clearances, serum urea and creatinine, and renal biopsy findings. There was a linear correlation (r equals 0-7; P less than 0-001) between the urinary F.D.P. excretion and the selectivity of the proteinuria such that patients with highly selective proteinuria excreted only small amounts of F.D.P. whereas those with non-selective proteinuria excreted much higher levels. There was a significant correlation between the urinary F.D.P. excretion and the urine:serum (U:S) ratio of IgG excretion but not with the U:S ratio or urinary excretion of albumin or transferrin. Sephadex G200 column chromatography of the concentrated urine in 26 cases showed that patients with highly selective proteinuria excreted predominantly F.D.P. of low molecular weight in the urine whereas those with non-selective proteinuria excreted mainly fibrinogen and products of high molecular weight. Hence the type and quantity of F.D.P. in the urine are determined primarily by the differential filtration of fibrinogen and the various degradation products from the plasma through the glomerular basement membrane, which in turn is determined by the "pore size" of the basement membrane. In clinical nephrology measurement of the urinary F.D.P. level provides a rapid and convenient means of estimating the differential protein clearance.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 803853      PMCID: PMC1672390          DOI: 10.1136/bmj.1.5955.419

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  Fibrin degradation products in renal parenchymal disease states and renal transplant patients.

Authors:  B C Shah; J L Ambrus; I B Mink; D J Albert; D Sampson; G P Murphy
Journal:  Transplantation       Date:  1972-12       Impact factor: 4.939

2.  Specific and sensitive determination of fibrinogen-degradation products by radioimmunoassay.

Authors:  Y B Gordon; M J Martin; A T McNeile; T Chard
Journal:  Lancet       Date:  1973-11-24       Impact factor: 79.321

3.  Intravascular coagulation and pre-eclamptic toxaemia.

Authors:  E N Wardle
Journal:  Lancet       Date:  1972-03-25       Impact factor: 79.321

4.  Fibrinogen breakdown products: identification and assay in serum and urine.

Authors:  H Rayner; F Parashevas; L G Israels; E D Israels
Journal:  J Lab Clin Med       Date:  1969-10

5.  Urinary fibrin-fibrinogen degradation products (FDP) and glomerulonephritis.

Authors:  U Hedner; M Ekberg; I M Nilsson
Journal:  Acta Med Scand       Date:  1974 Jan-Feb

6.  Typing of fibrinogen degradation products in urine in various clinical disorders.

Authors:  B N Bouma; U Hedner; I M Nilsson
Journal:  Scand J Clin Lab Invest       Date:  1971-06       Impact factor: 1.713

7.  Immunologically reactive equivalents of fibrinogen in sera and urine of children with renal disease.

Authors:  H Ekert; T M Barratt; C Chantler; M W Turner
Journal:  Arch Dis Child       Date:  1972-02       Impact factor: 3.791

8.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

9.  A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum.

Authors:  C Merskey; P Lalezari; A J Johnson
Journal:  Proc Soc Exp Biol Med       Date:  1969-07

10.  Urinary fibrinogen derivative excretion and intraglomerular fibrin deposition in glomerulonephritis.

Authors:  P Naish; D J Evans; D K Peters
Journal:  Br Med J       Date:  1974-03-23
View more
  5 in total

1.  Fibrinogen and fibrinogen/fibrin degradation products in the urine of rabbits infected with Trypanosoma (trypanozoon) brucei.

Authors:  P F Boreham; C A Facer
Journal:  Z Parasitenkd       Date:  1977-07-29

2.  Fibrin-fibrinogen degradation products in cerebrospinal fluid.

Authors:  M J Brueton; G R Breeze; J Stuart
Journal:  J Clin Pathol       Date:  1976-04       Impact factor: 3.411

3.  Coagulation and fibrinolytic activity of cerebrospinal fluid.

Authors:  M Anderson; K B Matthews; J Stuart
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

Review 4.  Hypercoagulability in the Nephrotic syndrome.

Authors:  K Andrassy; E Ritz; J Bommer
Journal:  Klin Wochenschr       Date:  1980-10-01

5.  Fibrin deposits in the glomeruli and fibrin/fibrinogen degradation products (FDP) in the blood and urine in some renal diseases.

Authors:  I Tishkov; C Tschoukanov; D Doytshinov; P Shipkova
Journal:  Int Urol Nephrol       Date:  1982       Impact factor: 2.370

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.